WA
CTIC

WFG Advisors’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History

WFG Advisors’s Portfolio CTIC Stock Details CTIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-740
Closed -$13K – 1915
2015
Q1 		$13K Buy
+740
New +$16.7K ﹤0.01% 1137

Other funds holding CTIC

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
LOAMU
Lombard Odier Asset Management (USA) New York $957M AUM 35.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return

WFG Advisors's CTIC Position: Q2 2015 in Review

WFG Advisors sold out of CTI BioPharma Corp. (DE) Common Stock (CTIC) in Q2 2015, closing a stake of 740 shares — an estimated $13K sold.

WFG Advisors first reported a position in CTIC in Q1 2015 and held it in 1 quarter. The position peaked at $13K in Q1 2015. 95 funds tracked by Wall St. Rank hold CTIC as of Q2 2015.

  • WFG Advisors reported no remaining CTI BioPharma Corp. (DE) Common Stock position as of Q2 2015 after selling out during the quarter.
  • WFG Advisors sold 740 CTI BioPharma Corp. (DE) Common Stock shares in Q2 2015, an estimated $13K.
  • WFG Advisors first reported a position in CTI BioPharma Corp. (DE) Common Stock in Q1 2015 and held it in 1 quarter.
  • WFG Advisors's CTI BioPharma Corp. (DE) Common Stock position peaked at $13K in Q1 2015.
  • 95 funds tracked by Wall St. Rank held CTI BioPharma Corp. (DE) Common Stock as of Q2 2015.

Based on WFG Advisors's 13F filing for Q2 2015, filed 13 Aug 2015.